An Open Label, Randomized, Phase 3 Clinical Trial of REGN2810 Versus Therapy of Investigator’s Choice Chemotherapy in Recurrent or Metastatic Platinum-Refractory Cervical Carcinoma
Trial Number
NCT03257267 (ClinicalTrials.gov ID)Contact Person
Status
Completed
Disease Site
Cervical
Lead Cooperative Group
Participating Groups
BGOG
MaNGO
MITO
NCRI